1-4 of 4
Eric Chevalier
Close
Sort by
Journal Articles

Potent Stem Cell Mobilization with the Novel CXCR4 Antagonist POL6326 - Results of a Phase IIa Dose Escalation Study in Comparison to G-CSF

Darja Karpova, PhD, Susanne Brauninger, MD, Eliza Wiercinska, PhD, Ariane Kraemer, B.Sc., Belinda Stock, Jochen Graff, MD, Christophe Escot, Garry Douglas, PhD, Barbara Romagnoli, PhD, Eric Chevalier, PhD, Klaus Dembowsky, MD PhD, Leon Hooftman, MD, Halvard Bonig, MD MA
Journal: Blood
Blood (2015) 126 (23): 511.
https://doi.org/10.1182/blood.V126.23.511.511
Published: 2015
Journal Articles

CXCR7-dependent angiogenic mononuclear cell trafficking regulates tumor progression in multiple myeloma

Abdel Kareem Azab, Ilyas Sahin, Feda Azab, Michele Moschetta, Yuji Mishima, Nicholas Burwick, Johann Zimmermann, Barbara Romagnoli, Kalpana Patel, Eric Chevalier, Aldo M. Roccaro, Irene M. Ghobrial
Journal: Blood
Blood (2014) 124 (12): 1905–1914.
https://doi.org/10.1182/blood-2014-02-558742
Published: 2014
Journal Articles

The Novel CXCR4 Antagonist POL5551 Decreases Surface CXCR4 (s-CXCR4) Expression, Inhibits Chemotaxis, and Enhances Chemosensitivity in Acute Lymphoblastic Leukemia (ALL)

Edward Allan R. Sison, MD, Daniel Magoon, Eric Chevalier, PhD, Klaus Dembowsky, MD, PhD, Patrick Brown, MD
Journal: Blood
Blood (2012) 120 (21): 780.
https://doi.org/10.1182/blood.V120.21.780.780
Published: 2012
Journal Articles

Rapid and Potent Mobilization of Murine Hematopoietic Stem and Progenitor Cells by the Novel CXCR4 Antagonist POL5551

Darja Karpova, M.Sc., Katrin Dauber, Dipl.biol., Gabriele Spohn, Ph.D., Doreen Chudziak, Dipl.biol., Eliza Wiercinska, Miriam Schulz, Barbara Romagnoli, Eric Chevalier, PhD, Kalpana Patel, Halvard Bonig, MD, MA
Journal: Blood
Blood (2012) 120 (21): 4100.
https://doi.org/10.1182/blood.V120.21.4100.4100
Published: 2012